Iomazenil

DB14971InvestigationalSmall molecule

Iomazenil is under investigation in clinical trial NCT01590277 (Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans).

Chemical structure of Iomazenil
Formula / weight
C15H14IN3O3 · 411.199 g/mol (avg)

Resolves to

Compound
UNII7DVX185FLQCAS127985-21-1ChEMBLCHEMBL2110679
Structure
InChIKeyFRIZVHMAECRUBR-UHFFFAOYSA-NSMILESCCOC(=O)C1=C2CN(C)C(=O)C3=C(I)C=CC=C3N2C=N1

What you can answer from here — as of April 23, 2025

3Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Iomazenil, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In